Vollständiger Abstract
Worum geht es in dieser Arbeit?
Background/Objectives: Kidney transplantation is the gold standard treatment for end-stage renal failure. Numerous studies have sought to identify biomarkers that can predict early outcomes. Neutrophil gelatinase-associated lipocalin (NGAL) is a biomarker that is hypothesised to be an important predictor of early surgical outcomes. Methods: A targeted narrative search was performed using prespecified search terms. Reference lists were searched to identify and yield more articles. Discussion: This review has identified several domains in which urinary and serum NGAL may be useful as well as limitations in its application. Conclusions: NGAL is a promising biomarker; however, further research is necessary to establish best practice in its use in the early post-operative phase.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Alexander A. Dermanis, Dominic Thompson, Georgios Koimtzis
- Quelle
- Journal of Clinical Medicine
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 2077-0383
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Alexander A. Dermanis, Dominic Thompson, Georgios Koimtzis (2026). The Role of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker in Predicting the Function of Kidney Grafts: A Literature Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15176803
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1